Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987 – NASDAQ

Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987
NASDAQ
(RTTNews.com) – Targacept Inc. (TRGT) announced revised top-line results from its exploratory Phase 2 clinical study of TC-6987 in asthma. After identifying an error in the application of the agreed statistical analysis plan, a reanalysis of the data
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of MarketWatch (press release)
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 StudyBenzinga

all 9 news articles »

View full post on asthma – Google News

Petitioners seek cleaner emissions from Portsmouth’s Schiller Station – Seacoastonline.com

Petitioners seek cleaner emissions from Portsmouth's Schiller Station
Seacoastonline.com
The clubs point to a 2011 American Lung Association report indicating that virtually the entire York County, Maine, population of 201876, is at risk for chronic respiratory and pulmonary illnesses, including asthma, bronchitis, emphysema and
Environmental Groups Ask EPA to Investigate Schiller Plant EmissionsNew Hampshire Public Radio

all 2 news articles »

View full post on asthma – Google News

Dover spa raises funds, awareness after co-worker dies from asthma – Foster’s Daily Democrat

Dover spa raises funds, awareness after co-worker dies from asthma
Foster’s Daily Democrat
By LAURENNE RAMSDELL DOVER — To honor a coworker who unexpectedly passed away three months ago, the staff at Dover Skin Health and Medi Spa are finding ways to raise awareness about the severity of asthma. On Dec. 18, 2011, Nikki Salmon passed away

View full post on asthma – Google News

Targacept slips on mixed results from drug studies – BusinessWeek

Targacept slips on mixed results from drug studies
BusinessWeek
Shares of Targacept Inc. declined Tuesday after the company said its drug candidate TC-6987 worked as a treatment for asthma in a clinical trial, but failed as a treatment for diabetes. Targacept said asthma patients who were treated with TC-6987 for
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of MarketWatch (press release)
Targacept discontinues two clinical trials, reports success with a thirdWinston-Salem Journal (blog)
Asthma drug shows promise, diabetes study fails in Targacept phase 2 trialsMedCity News

all 41 news articles »

View full post on asthma – Google News

Air pollution from trucks and low-quality heating oil may explain childhood … – Science Codex

Air pollution from trucks and low-quality heating oil may explain childhood
Science Codex
Where a child lives can greatly affect his or her risk for asthma. According to a new study by scientists at Columbia University, neighborhood differences in rates of childhood asthma may be explained by varying levels of air pollution from trucks and

and more »

View full post on asthma – Google News

Targacept reports mixed data from two trials – Reuters

Targacept reports mixed data from two trials
Reuters
* Says asthma trial meets main goals * Says diabetes trial did not meet main goal * Targacept drops development of drug for diabetes March 27 (Reuters) – Targacept said an experimental drug proved effective in a mid-stage asthma trial, but failed to
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of MarketWatch (press release)
Targacept Dropping Development Of Diabetes Drug; Shares FallWall Street Journal
Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987RTT News

all 14 news articles »

View full post on asthma – Google News

Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987 – RTT News

Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987
RTT News
(RTTNews) – Targacept Inc. (TRGT: News ) announced top-line results from two separate exploratory Phase 2 studies of its product candidate TC-6987 conducted in the US, one in asthma and one in type 2 diabetes. In the asthma study, oral TC-6987 met
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of MarketWatch (press release)

all 6 news articles »

View full post on asthma – Google News

Study says there’s no permanent relief from asthma – Globe and Mail


CBC.ca

Study says there's no permanent relief from asthma
Globe and Mail
If you have been diagnosed with asthma, you had better get used to it, researchers say. A new study suggests it is a life-long affliction. Some earlier research involving relatively small groups of patients found many people are symptom-free for long
Asthma likely to be a lifetime conditionCBC.ca

all 2 news articles »

View full post on asthma – Google News